Journal
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
Volume 15, Issue 5, Pages 478-485Publisher
WILEY
DOI: 10.1111/j.1756-185X.2012.01814.x
Keywords
B lymphocyte stimulator (BlyS); rheumatoid arthritis; sero-negative; sero-positive
Categories
Ask authors/readers for more resources
Aim To investigate the differences of B lymphocyte stimulator (BlyS) level and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis (RA) patients. Methods Sixty-nine RA patients were enrolled into this study and their clinical data were recorded. The BlyS levels in plasma, frequency of T and B lymphocytes, as well as T-helper (Th) subgroups were compared between sero-negative and sero-positive RA patients. Furthermore, the correlations between clinical features and immunological features were analyzed. Results The plasma BlyS level in sero-negative RA was higher compared to the sero-positive RA patients (1.73 +/- 1.71 vs. 0.99 +/- 0.59 ng/mL, P < 0.05) and osteoarthritis (OA) patients (1.73 +/- 1.71 vs. 0.59 +/- 0.12 ng/mL, P < 0.05). Plasma BlyS level was correlated with disease activity score (DAS-28, erythrocyte sedimentation rate and C-reactive protein), but had no correlation with the titers of rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies. The patients with more advanced changes in X-rays had high plasma BlyS levels. No significant differences in the frequency of T lymphocytes, Th subpopulations and B lymphocytes in peripheral blood were observed between sero-negative and sero-positive RA patients. Conclusions Plasma BlyS level was correlated with disease activity and radiological progress, which indicates that plasma BlyS level may become a useful biological marker to reflect DAS and to predict RA prognosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available